offer
all report title image
  • Published On : Mar 2022
  • Code : CMI4989
  • Industry : Pharmaceutical
  • Pages : 180
  • Formats :

Vaccination enhances health of animals, thus improving their life expectancies. Veterinary vaccines are available for diseases such as rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant, as it impacts the supply of dairy products, meat, and other poultry products.

Vaccines are broadly classified as inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, and subunit and DNA vaccines. Veterinary vaccines impact animal health and production quality and also ensure good health of general human population through consumption of various food procured from animals.

Global Animal Vaccines Market - Impact of the Coronavirus (COVID-19) Pandemic

The rapid spread of COVID-19 across the globe is posing a challenge for veterinary healthcare systems worldwide. According to data published by the Centers for Disease Control & Protection (CDC) in November 2021, the risk of animals spreading SARS-CoV-2, the virus that causes COVID-19, is low. Currently, there is no evidence that animals play a significant role in spreading SARS-CoV-2. Due to social distancing policies, most of the veterinary visits are done through telemedicine medium such as video calling from smart phones or tablet devices. For instance, in April 2020, Boehringer Ingelheim U.K. collaborated with VetHelpDirect, that offered all U.K. veterinary practices free access to an online video consultation platform for a period of three months during the pandemic. By offering an alternative to face-to-face consultation, the online platform is a means of continuing care for animals while protecting both clients and staff from the spread of COVID-19

Veterinary research centers are focused on developing a COVID-19 vaccine for animals as a preventive measures. For instance, in June 2020, the Indian Veterinary Research Institute (IVRI), announced plans of developing a vaccine and diagnostic kits, and study the transmission dynamics of COVID-19 in pets and wild animals. Moreover, this project will be carried out in collaboration with IIT-Roorkee, India.

Furthermore, in the near future, global animal vaccines market is expected witness growth, owing to the increasing demand for vaccinations for animals. Following the re-opening of manufacturing units, demand and supply are projected to meet expectations of customers whose pet vaccine schedules were delayed due to the pandemic.

The global animal vaccines market is estimated to be valued at US$ 7,119.7 Mn in 2021, and is expected to exhibit a CAGR of 6.6% over the forecast period (2021-2028).

Figure 1: Global Animal Vaccines Market Share (%) Analysis, by Product Type, 2021

Animal Vaccines  | Coherent Market Insights

Increasing number of R&D initiatives is the major factor that is expected to drive the market growth over the forecast period.

Market players are engaged in conducting research projects to help understand viral diseases, in order to discover vaccination in order to prevent animals from various diseases. For instance, in June 2018, Regeneron Pharmaceuticals, Inc. and Zoetis, Inc. announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

Increasing Product Launches and Approvals 

Market players are focusing on launching generic versions of opioid medications, which is expected to augment the market growth over the forecast period. For instance, in May 2020, MSD Animal Health, a division of Merck & Co., Inc., launched NOBIVAC Myxo-RHD PLUS vaccine to reduce mortality and clinical signs of the two most common viral diseases in rabbits: myxomatosis and rabbit haemorrhagic disease (RHD) caused by both classic (RHDV1) and variant (RHDV2) strains.

CMI table icon

Animal Vaccines Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 7,119.7 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 6.6% 2028 Value Projection: US$ 11,156.3 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
  • By Application: Companion Animal, Livestock Animal, Poultry, Aquaculture
  • By Distribution Channel: Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others 
Companies covered:

Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó

Growth Drivers:
  • Increasing number of R&D initiatives
  • Increasing product launches
Restraints & Challenges:
  • High storage costs and complex manufacturing methodology of vaccines

Global Animal Vaccines Market – Restraints

Proper vaccine storage and handling is important factor in preventing and eradicating various common vaccine-preventable diseases. Yet, each year, storage and handling errors result in revaccination of several pet animals and significant financial loss due to wasted vaccines. Failure to store and handle vaccines properly can reduce vaccine potency, resulting in inadequate immune responses in pet animals and poor protection against diseases, which is anticipated to hinder the market growth.

Global Animal Vaccines Market – Regional Analysis

On the basis of region, the global animal vaccines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global animal vaccines market over the forecast period, owing to increasing initiatives by private and government organizations related to animal vaccination. For instance, in January 2020, the U.S. Department of Agriculture’s (U.S.DA) Animal and Plant Health Inspection Service (APHIS) announced to award US$ 10.2 million to support disease prevention and emergency response training, and to develop the National Animal Vaccine and Veterinary Countermeasures Bank (NAVVCB).

Figure 2: Global Animal Vaccines Market Value (US$ Mn), by Region, 2021

Animal Vaccines  | Coherent Market Insights

Global Animal Vaccines Market – Competitive Landscape

Major players operating in the global animal vaccines market include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó.

Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.

Market Dynamics

Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.

Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.

Key features of the study:

  • This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global animal vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market

Detailed Segmentation:

  • Global Animal Vaccines Market, By Product Type :
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Global Animal Vaccines Market, By Application:
    • Companion Animal
    • Livestock Animal
    • Poultry
    • Aquaculture
  • Global Animal Vaccines Market, By Distribution Channel:
    • Veterinary Clinics
    • Veterinary Hospitals
    • Veterinary Research Institutes
    • Others
  • Global Animal Vaccines Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Merck & Co., Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim International GmbH.
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Ceva
    • HIPRA
    • Romvac Company Sa
    • Biovac
    • Vaxxinova International BV
    • Biogénesis Bagó

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global animal vaccines market is expected to exhibit a CAGR of 6.6% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 7,119.7 Mn in 2021.
Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó are some of the prominent players operating in the market.
The market is expected to be valued at US$ 11,156.3 Mn in 2028.
North America is the prominent region in the market.
Increasing number of R&D initiatives and increasing product launches, are expected to drive growth of the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo